Eliem Therapeutics OverviewEliem Therapeutics Other Income Expense Net
Other Income/Expense Net for ELYM.
Quarterly Other Income/Expense
$1.49M
↓ 33.44% YoY
As of Mar 31, 2026
Annual Other Income/Expense (TTM)
$7.28M
↓ 30.02% YoY
Trailing 12 months ending Mar 31, 2026